The IL-33/ST2 Axis Is Associated with Human Visceral Leishmaniasis and Suppresses Th1 Responses in the Livers of BALB/c Mice Infected with <named-content content-type="genus-species">Leishmania donovani</named-content>

ABSTRACT During visceral leishmaniasis, the control of hepatic parasite burden is mainly due to granuloma assembly in a microenvironment consisting of both Th1 and Th2 components. Using enzyme-linked immunosorbent assay (ELISA) dosages, quantitative PCR (qPCR), immunohistochemistry, and flow cytomet...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Octavie Rostan, Jean-Pierre Gangneux, Claire Piquet-Pellorce, Christelle Manuel, Andrew N. J. McKenzie, Claude Guiguen, Michel Samson, Florence Robert-Gangneux
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2013
Materias:
Acceso en línea:https://doaj.org/article/89eeccdbd1fc416dacf0be4a9a74314c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:89eeccdbd1fc416dacf0be4a9a74314c
record_format dspace
spelling oai:doaj.org-article:89eeccdbd1fc416dacf0be4a9a74314c2021-11-15T15:42:47ZThe IL-33/ST2 Axis Is Associated with Human Visceral Leishmaniasis and Suppresses Th1 Responses in the Livers of BALB/c Mice Infected with <named-content content-type="genus-species">Leishmania donovani</named-content>10.1128/mBio.00383-132150-7511https://doaj.org/article/89eeccdbd1fc416dacf0be4a9a74314c2013-11-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.00383-13https://doaj.org/toc/2150-7511ABSTRACT During visceral leishmaniasis, the control of hepatic parasite burden is mainly due to granuloma assembly in a microenvironment consisting of both Th1 and Th2 components. Using enzyme-linked immunosorbent assay (ELISA) dosages, quantitative PCR (qPCR), immunohistochemistry, and flow cytometry, we studied the role of interleukin-33 (IL-33), a recently described cytokine signaling through the ST2 receptor, during visceral leishmaniasis. We showed that a higher level of IL-33 was detected in the serum of patients with visceral leishmaniasis than in that from healthy donors and demonstrated the presence of IL-33+ cells in a liver biopsy specimen from a patient. Similarly, in BALB/c mice experimentally infected with L. donovani, a higher level of IL-33 was detected in the serum, as well as the presence of IL-33+ cells and ST2+ cells in the mouse liver. In ST2−/− BALB/c mice, better control of the hepatic parasite burden and reduced hepatomegaly were observed. This was associated with strong induction of Th1 cytokines (gamma interferon [IFN-γ] and IL-12) compared to the level in wild-type (WT) mice and better recruitment of myeloid cells associated with strongly induced chemokines (CCL2 and CXCL2) and receptors (CCR2 and CXCR2). Conversely, BALB/c mice treated twice weekly with recombinant IL-33 showed a dramatically reduced induction of Th1 cytokines and delayed inhibition of monocyte and neutrophil recruitment in the liver, which was associated with reduced KC/CXCL1 and CXCR2 expression. Taken together, our results suggest that IL-33 could be a new deleterious regulator of the hepatic immune response against Leishmania donovani, via the repression of the Th1 response and myeloid cell recruitment. IMPORTANCE Visceral leishmaniasis is a life-threatening systemic disease due to the Leishmania protozoa L. infantum and L. donovani and is ranked by the World Health Organization as the second most important protozoan parasitic disease after malaria for its grave morbidity, high mortality, and global distribution. Leishmania parasites subvert the host’s immune response to propagate to target organs, including the spleen, the bone marrow, and the liver. Control of hepatic parasite burdens depends on a delicate and poorly understood Th1/Th2 immune balance. To better understand this complex immune response, new cytokines are interesting targets for research studies. IL-33 is a newly described cytokine usually associated with Th2 response and involved in different diseases, including infectious diseases and hepatitis. Our results suggest that IL-33 could be a new factor of susceptibility and a potential prognostic marker during visceral leishmaniasis.Octavie RostanJean-Pierre GangneuxClaire Piquet-PellorceChristelle ManuelAndrew N. J. McKenzieClaude GuiguenMichel SamsonFlorence Robert-GangneuxAmerican Society for MicrobiologyarticleMicrobiologyQR1-502ENmBio, Vol 4, Iss 5 (2013)
institution DOAJ
collection DOAJ
language EN
topic Microbiology
QR1-502
spellingShingle Microbiology
QR1-502
Octavie Rostan
Jean-Pierre Gangneux
Claire Piquet-Pellorce
Christelle Manuel
Andrew N. J. McKenzie
Claude Guiguen
Michel Samson
Florence Robert-Gangneux
The IL-33/ST2 Axis Is Associated with Human Visceral Leishmaniasis and Suppresses Th1 Responses in the Livers of BALB/c Mice Infected with <named-content content-type="genus-species">Leishmania donovani</named-content>
description ABSTRACT During visceral leishmaniasis, the control of hepatic parasite burden is mainly due to granuloma assembly in a microenvironment consisting of both Th1 and Th2 components. Using enzyme-linked immunosorbent assay (ELISA) dosages, quantitative PCR (qPCR), immunohistochemistry, and flow cytometry, we studied the role of interleukin-33 (IL-33), a recently described cytokine signaling through the ST2 receptor, during visceral leishmaniasis. We showed that a higher level of IL-33 was detected in the serum of patients with visceral leishmaniasis than in that from healthy donors and demonstrated the presence of IL-33+ cells in a liver biopsy specimen from a patient. Similarly, in BALB/c mice experimentally infected with L. donovani, a higher level of IL-33 was detected in the serum, as well as the presence of IL-33+ cells and ST2+ cells in the mouse liver. In ST2−/− BALB/c mice, better control of the hepatic parasite burden and reduced hepatomegaly were observed. This was associated with strong induction of Th1 cytokines (gamma interferon [IFN-γ] and IL-12) compared to the level in wild-type (WT) mice and better recruitment of myeloid cells associated with strongly induced chemokines (CCL2 and CXCL2) and receptors (CCR2 and CXCR2). Conversely, BALB/c mice treated twice weekly with recombinant IL-33 showed a dramatically reduced induction of Th1 cytokines and delayed inhibition of monocyte and neutrophil recruitment in the liver, which was associated with reduced KC/CXCL1 and CXCR2 expression. Taken together, our results suggest that IL-33 could be a new deleterious regulator of the hepatic immune response against Leishmania donovani, via the repression of the Th1 response and myeloid cell recruitment. IMPORTANCE Visceral leishmaniasis is a life-threatening systemic disease due to the Leishmania protozoa L. infantum and L. donovani and is ranked by the World Health Organization as the second most important protozoan parasitic disease after malaria for its grave morbidity, high mortality, and global distribution. Leishmania parasites subvert the host’s immune response to propagate to target organs, including the spleen, the bone marrow, and the liver. Control of hepatic parasite burdens depends on a delicate and poorly understood Th1/Th2 immune balance. To better understand this complex immune response, new cytokines are interesting targets for research studies. IL-33 is a newly described cytokine usually associated with Th2 response and involved in different diseases, including infectious diseases and hepatitis. Our results suggest that IL-33 could be a new factor of susceptibility and a potential prognostic marker during visceral leishmaniasis.
format article
author Octavie Rostan
Jean-Pierre Gangneux
Claire Piquet-Pellorce
Christelle Manuel
Andrew N. J. McKenzie
Claude Guiguen
Michel Samson
Florence Robert-Gangneux
author_facet Octavie Rostan
Jean-Pierre Gangneux
Claire Piquet-Pellorce
Christelle Manuel
Andrew N. J. McKenzie
Claude Guiguen
Michel Samson
Florence Robert-Gangneux
author_sort Octavie Rostan
title The IL-33/ST2 Axis Is Associated with Human Visceral Leishmaniasis and Suppresses Th1 Responses in the Livers of BALB/c Mice Infected with <named-content content-type="genus-species">Leishmania donovani</named-content>
title_short The IL-33/ST2 Axis Is Associated with Human Visceral Leishmaniasis and Suppresses Th1 Responses in the Livers of BALB/c Mice Infected with <named-content content-type="genus-species">Leishmania donovani</named-content>
title_full The IL-33/ST2 Axis Is Associated with Human Visceral Leishmaniasis and Suppresses Th1 Responses in the Livers of BALB/c Mice Infected with <named-content content-type="genus-species">Leishmania donovani</named-content>
title_fullStr The IL-33/ST2 Axis Is Associated with Human Visceral Leishmaniasis and Suppresses Th1 Responses in the Livers of BALB/c Mice Infected with <named-content content-type="genus-species">Leishmania donovani</named-content>
title_full_unstemmed The IL-33/ST2 Axis Is Associated with Human Visceral Leishmaniasis and Suppresses Th1 Responses in the Livers of BALB/c Mice Infected with <named-content content-type="genus-species">Leishmania donovani</named-content>
title_sort il-33/st2 axis is associated with human visceral leishmaniasis and suppresses th1 responses in the livers of balb/c mice infected with <named-content content-type="genus-species">leishmania donovani</named-content>
publisher American Society for Microbiology
publishDate 2013
url https://doaj.org/article/89eeccdbd1fc416dacf0be4a9a74314c
work_keys_str_mv AT octavierostan theil33st2axisisassociatedwithhumanvisceralleishmaniasisandsuppressesth1responsesintheliversofbalbcmiceinfectedwithnamedcontentcontenttypegenusspeciesleishmaniadonovaninamedcontent
AT jeanpierregangneux theil33st2axisisassociatedwithhumanvisceralleishmaniasisandsuppressesth1responsesintheliversofbalbcmiceinfectedwithnamedcontentcontenttypegenusspeciesleishmaniadonovaninamedcontent
AT clairepiquetpellorce theil33st2axisisassociatedwithhumanvisceralleishmaniasisandsuppressesth1responsesintheliversofbalbcmiceinfectedwithnamedcontentcontenttypegenusspeciesleishmaniadonovaninamedcontent
AT christellemanuel theil33st2axisisassociatedwithhumanvisceralleishmaniasisandsuppressesth1responsesintheliversofbalbcmiceinfectedwithnamedcontentcontenttypegenusspeciesleishmaniadonovaninamedcontent
AT andrewnjmckenzie theil33st2axisisassociatedwithhumanvisceralleishmaniasisandsuppressesth1responsesintheliversofbalbcmiceinfectedwithnamedcontentcontenttypegenusspeciesleishmaniadonovaninamedcontent
AT claudeguiguen theil33st2axisisassociatedwithhumanvisceralleishmaniasisandsuppressesth1responsesintheliversofbalbcmiceinfectedwithnamedcontentcontenttypegenusspeciesleishmaniadonovaninamedcontent
AT michelsamson theil33st2axisisassociatedwithhumanvisceralleishmaniasisandsuppressesth1responsesintheliversofbalbcmiceinfectedwithnamedcontentcontenttypegenusspeciesleishmaniadonovaninamedcontent
AT florencerobertgangneux theil33st2axisisassociatedwithhumanvisceralleishmaniasisandsuppressesth1responsesintheliversofbalbcmiceinfectedwithnamedcontentcontenttypegenusspeciesleishmaniadonovaninamedcontent
AT octavierostan il33st2axisisassociatedwithhumanvisceralleishmaniasisandsuppressesth1responsesintheliversofbalbcmiceinfectedwithnamedcontentcontenttypegenusspeciesleishmaniadonovaninamedcontent
AT jeanpierregangneux il33st2axisisassociatedwithhumanvisceralleishmaniasisandsuppressesth1responsesintheliversofbalbcmiceinfectedwithnamedcontentcontenttypegenusspeciesleishmaniadonovaninamedcontent
AT clairepiquetpellorce il33st2axisisassociatedwithhumanvisceralleishmaniasisandsuppressesth1responsesintheliversofbalbcmiceinfectedwithnamedcontentcontenttypegenusspeciesleishmaniadonovaninamedcontent
AT christellemanuel il33st2axisisassociatedwithhumanvisceralleishmaniasisandsuppressesth1responsesintheliversofbalbcmiceinfectedwithnamedcontentcontenttypegenusspeciesleishmaniadonovaninamedcontent
AT andrewnjmckenzie il33st2axisisassociatedwithhumanvisceralleishmaniasisandsuppressesth1responsesintheliversofbalbcmiceinfectedwithnamedcontentcontenttypegenusspeciesleishmaniadonovaninamedcontent
AT claudeguiguen il33st2axisisassociatedwithhumanvisceralleishmaniasisandsuppressesth1responsesintheliversofbalbcmiceinfectedwithnamedcontentcontenttypegenusspeciesleishmaniadonovaninamedcontent
AT michelsamson il33st2axisisassociatedwithhumanvisceralleishmaniasisandsuppressesth1responsesintheliversofbalbcmiceinfectedwithnamedcontentcontenttypegenusspeciesleishmaniadonovaninamedcontent
AT florencerobertgangneux il33st2axisisassociatedwithhumanvisceralleishmaniasisandsuppressesth1responsesintheliversofbalbcmiceinfectedwithnamedcontentcontenttypegenusspeciesleishmaniadonovaninamedcontent
_version_ 1718427596821102592